TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation
Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect...
Gespeichert in:
Veröffentlicht in: | American journal of medical genetics. Part A 2018-12, Vol.176 (12), p.2813-2818 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2818 |
---|---|
container_issue | 12 |
container_start_page | 2813 |
container_title | American journal of medical genetics. Part A |
container_volume | 176 |
creator | Lemattre, C. Thevenon, J. Duffourd, Y. Nambot, S. Haquet, E. Vuadelle, B. Genevieve, D. Sarda, P. Bruel, A. L. Kuentz, P. Wells, C. F. Faivre, L. Willems, M. |
description | Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont‐like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont‐like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies. |
doi_str_mv | 10.1002/ajmg.a.40510 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01915588v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2126901522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3980-4c37ad411456078841076060f4d32bae9531287f9d257ee8fe4e084ecaac289d3</originalsourceid><addsrcrecordid>eNp90c9P2zAUB3ALbQLGuO08Wdplk2h5_hnn2FUDhoqYUJG4WSZ5GamSuLOTTfnvcRfWww6cbD199JWfv4R8YDBnAPzcbdqfczeXoBgckGOmFJ9JI8Sb_Z2rI_Iuxg2AAJXpQ3IkQGhlMnlM7Prrij3cMdoOvetr30Vad_RHjWHru57GsSuDb5G6gLTzPQ0Y-1AXPZa097R_wjQphhAw4e18PQYp9XKM-7j35G3lmoinL-cJub_4tl5ezVa3l9-Xi9WsELmBmSxE5krJmFQaMmMkg0yDhkqWgj86zJVg3GRVXnKVIZoKJYKRWDhXcJOX4oR8mXKfXGO3oW5dGK13tb1arOxuBixP32HMb5bs58lug_81pIVsW8cCm8Z16IdoOeM6B6Y4T_TTf3Tjh9ClTZLSLNOGSZnU2aSK4GMMWO1fwMDuSrK7kqyzf0tK_ONL6PDYYrnH_1pJQE7gT93g-GqYXVzfXC6m3GcQVpsV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2161768144</pqid></control><display><type>article</type><title>TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation</title><source>Wiley Online Library All Journals</source><creator>Lemattre, C. ; Thevenon, J. ; Duffourd, Y. ; Nambot, S. ; Haquet, E. ; Vuadelle, B. ; Genevieve, D. ; Sarda, P. ; Bruel, A. L. ; Kuentz, P. ; Wells, C. F. ; Faivre, L. ; Willems, M.</creator><creatorcontrib>Lemattre, C. ; Thevenon, J. ; Duffourd, Y. ; Nambot, S. ; Haquet, E. ; Vuadelle, B. ; Genevieve, D. ; Sarda, P. ; Bruel, A. L. ; Kuentz, P. ; Wells, C. F. ; Faivre, L. ; Willems, M.</creatorcontrib><description>Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont‐like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont‐like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.</description><identifier>ISSN: 1552-4825</identifier><identifier>EISSN: 1552-4833</identifier><identifier>DOI: 10.1002/ajmg.a.40510</identifier><identifier>PMID: 30365874</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Gene deletion ; Genetics ; Life Sciences ; Localization ; Molecular modelling ; Mutation ; Phenotypes ; Pierpont syndrome ; TBL1XR1</subject><ispartof>American journal of medical genetics. Part A, 2018-12, Vol.176 (12), p.2813-2818</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3980-4c37ad411456078841076060f4d32bae9531287f9d257ee8fe4e084ecaac289d3</citedby><cites>FETCH-LOGICAL-c3980-4c37ad411456078841076060f4d32bae9531287f9d257ee8fe4e084ecaac289d3</cites><orcidid>0000-0001-9770-444X ; 0000-0003-2814-6303 ; 0000-0002-2959-0935 ; 0000-0001-6928-6287</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajmg.a.40510$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajmg.a.40510$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30365874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://u-bourgogne.hal.science/hal-01915588$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Lemattre, C.</creatorcontrib><creatorcontrib>Thevenon, J.</creatorcontrib><creatorcontrib>Duffourd, Y.</creatorcontrib><creatorcontrib>Nambot, S.</creatorcontrib><creatorcontrib>Haquet, E.</creatorcontrib><creatorcontrib>Vuadelle, B.</creatorcontrib><creatorcontrib>Genevieve, D.</creatorcontrib><creatorcontrib>Sarda, P.</creatorcontrib><creatorcontrib>Bruel, A. L.</creatorcontrib><creatorcontrib>Kuentz, P.</creatorcontrib><creatorcontrib>Wells, C. F.</creatorcontrib><creatorcontrib>Faivre, L.</creatorcontrib><creatorcontrib>Willems, M.</creatorcontrib><title>TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation</title><title>American journal of medical genetics. Part A</title><addtitle>Am J Med Genet A</addtitle><description>Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont‐like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont‐like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.</description><subject>Gene deletion</subject><subject>Genetics</subject><subject>Life Sciences</subject><subject>Localization</subject><subject>Molecular modelling</subject><subject>Mutation</subject><subject>Phenotypes</subject><subject>Pierpont syndrome</subject><subject>TBL1XR1</subject><issn>1552-4825</issn><issn>1552-4833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp90c9P2zAUB3ALbQLGuO08Wdplk2h5_hnn2FUDhoqYUJG4WSZ5GamSuLOTTfnvcRfWww6cbD199JWfv4R8YDBnAPzcbdqfczeXoBgckGOmFJ9JI8Sb_Z2rI_Iuxg2AAJXpQ3IkQGhlMnlM7Prrij3cMdoOvetr30Vad_RHjWHru57GsSuDb5G6gLTzPQ0Y-1AXPZa097R_wjQphhAw4e18PQYp9XKM-7j35G3lmoinL-cJub_4tl5ezVa3l9-Xi9WsELmBmSxE5krJmFQaMmMkg0yDhkqWgj86zJVg3GRVXnKVIZoKJYKRWDhXcJOX4oR8mXKfXGO3oW5dGK13tb1arOxuBixP32HMb5bs58lug_81pIVsW8cCm8Z16IdoOeM6B6Y4T_TTf3Tjh9ClTZLSLNOGSZnU2aSK4GMMWO1fwMDuSrK7kqyzf0tK_ONL6PDYYrnH_1pJQE7gT93g-GqYXVzfXC6m3GcQVpsV</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Lemattre, C.</creator><creator>Thevenon, J.</creator><creator>Duffourd, Y.</creator><creator>Nambot, S.</creator><creator>Haquet, E.</creator><creator>Vuadelle, B.</creator><creator>Genevieve, D.</creator><creator>Sarda, P.</creator><creator>Bruel, A. L.</creator><creator>Kuentz, P.</creator><creator>Wells, C. F.</creator><creator>Faivre, L.</creator><creator>Willems, M.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-9770-444X</orcidid><orcidid>https://orcid.org/0000-0003-2814-6303</orcidid><orcidid>https://orcid.org/0000-0002-2959-0935</orcidid><orcidid>https://orcid.org/0000-0001-6928-6287</orcidid></search><sort><creationdate>201812</creationdate><title>TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation</title><author>Lemattre, C. ; Thevenon, J. ; Duffourd, Y. ; Nambot, S. ; Haquet, E. ; Vuadelle, B. ; Genevieve, D. ; Sarda, P. ; Bruel, A. L. ; Kuentz, P. ; Wells, C. F. ; Faivre, L. ; Willems, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3980-4c37ad411456078841076060f4d32bae9531287f9d257ee8fe4e084ecaac289d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Gene deletion</topic><topic>Genetics</topic><topic>Life Sciences</topic><topic>Localization</topic><topic>Molecular modelling</topic><topic>Mutation</topic><topic>Phenotypes</topic><topic>Pierpont syndrome</topic><topic>TBL1XR1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lemattre, C.</creatorcontrib><creatorcontrib>Thevenon, J.</creatorcontrib><creatorcontrib>Duffourd, Y.</creatorcontrib><creatorcontrib>Nambot, S.</creatorcontrib><creatorcontrib>Haquet, E.</creatorcontrib><creatorcontrib>Vuadelle, B.</creatorcontrib><creatorcontrib>Genevieve, D.</creatorcontrib><creatorcontrib>Sarda, P.</creatorcontrib><creatorcontrib>Bruel, A. L.</creatorcontrib><creatorcontrib>Kuentz, P.</creatorcontrib><creatorcontrib>Wells, C. F.</creatorcontrib><creatorcontrib>Faivre, L.</creatorcontrib><creatorcontrib>Willems, M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>American journal of medical genetics. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lemattre, C.</au><au>Thevenon, J.</au><au>Duffourd, Y.</au><au>Nambot, S.</au><au>Haquet, E.</au><au>Vuadelle, B.</au><au>Genevieve, D.</au><au>Sarda, P.</au><au>Bruel, A. L.</au><au>Kuentz, P.</au><au>Wells, C. F.</au><au>Faivre, L.</au><au>Willems, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation</atitle><jtitle>American journal of medical genetics. Part A</jtitle><addtitle>Am J Med Genet A</addtitle><date>2018-12</date><risdate>2018</risdate><volume>176</volume><issue>12</issue><spage>2813</spage><epage>2818</epage><pages>2813-2818</pages><issn>1552-4825</issn><eissn>1552-4833</eissn><abstract>Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole‐exome sequencing. A dominant‐negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont‐like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont‐like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>30365874</pmid><doi>10.1002/ajmg.a.40510</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9770-444X</orcidid><orcidid>https://orcid.org/0000-0003-2814-6303</orcidid><orcidid>https://orcid.org/0000-0002-2959-0935</orcidid><orcidid>https://orcid.org/0000-0001-6928-6287</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-4825 |
ispartof | American journal of medical genetics. Part A, 2018-12, Vol.176 (12), p.2813-2818 |
issn | 1552-4825 1552-4833 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_01915588v1 |
source | Wiley Online Library All Journals |
subjects | Gene deletion Genetics Life Sciences Localization Molecular modelling Mutation Phenotypes Pierpont syndrome TBL1XR1 |
title | TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A42%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TBL1XR1%20mutations%20in%20Pierpont%20syndrome%20are%20not%20restricted%20to%20the%20recurrent%20p.Tyr446Cys%20mutation&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20A&rft.au=Lemattre,%20C.&rft.date=2018-12&rft.volume=176&rft.issue=12&rft.spage=2813&rft.epage=2818&rft.pages=2813-2818&rft.issn=1552-4825&rft.eissn=1552-4833&rft_id=info:doi/10.1002/ajmg.a.40510&rft_dat=%3Cproquest_hal_p%3E2126901522%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2161768144&rft_id=info:pmid/30365874&rfr_iscdi=true |